[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …

DO Kleindorfer, A Towfighi, S Chaturvedi, KM Cockroft… - Stroke, 2021 - journals.lww.com
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Large-vessel vasculitis

D Pugh, M Karabayas, N Basu, MC Cid… - Nature Reviews …, 2021 - nature.com
Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches
and is the most common primary vasculitis in adults. LVV comprises two distinct conditions …

2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint …

Writing Committee Members, EM Isselbacher… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

C Ponte, PC Grayson, JC Robson, R Suppiah… - Annals of the …, 2022 - ard.bmj.com
Objective To develop and validate updated classification criteria for giant cell arteritis (GCA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis

M Maz, SA Chung, A Abril, CA Langford… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large …

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and …

GC Drosos, D Vedder, E Houben, L Boekel… - Annals of the …, 2022 - ard.bmj.com
Objective To develop recommendations for cardiovascular risk (CVR) management in gout,
vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD) …

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

C Dejaco, S Ramiro, M Bond, P Bosch… - Annals of the …, 2024 - ard.bmj.com
Objectives To update the EULAR recommendations for the use of imaging modalities in
primary large vessel vasculitis (LVV). Methods A systematic literature review update was …

Blue-ringed octopus-inspired microneedle patch for robust tissue surface adhesion and active injection drug delivery

Z Zhu, J Wang, X Pei, J Chen, X Wei, Y Liu, P Xia… - Science …, 2023 - science.org
Intratissue topical medication is important for the treatment of cutaneous, mucosal or
splanchnic diseases. However, penetrating surface barriers to providing adequate and …

Management of central retinal artery occlusion: a scientific statement from the American Heart Association

B Mac Grory, M Schrag, V Biousse, KL Furie… - Stroke, 2021 - Am Heart Assoc
Purpose: Central retinal artery occlusion (CRAO) is a form of acute ischemic stroke that
causes severe visual loss and is a harbinger of further cerebrovascular and cardiovascular …

Retinal vascular occlusions

IU Scott, PA Campochiaro, NJ Newman, V Biousse - The Lancet, 2020 - thelancet.com
Acute retinal vascular occlusions are common causes of visual impairment. Although both
retinal artery occlusions and retinal vein occlusions are associated with increased age and …